Placeholder

New Medical Breakthroughs Are Changing Alzheimer’s Diagnoses & Treatment

77 WABC Radio • November 15, 2026 • 5m 54s

New Medical Breakthroughs Are Changing Alzheimer’s Diagnoses & Treatment

The Cats Roundtable with John Catsimatidis — Featured Medical Commentary.

Do you believe the latest breakthroughs in Alzheimer’s diagnosis and treatment are receiving enough public attention?

The future of Alzheimer’s treatment is changing—and there is new hope for millions of families.

Dr. Mason Blake Pimsler, MD, JD joined John Catsimatidis on 77 WABC Radio to discuss how new diagnostic tools and disease-modifying therapies are reshaping the future of Alzheimer’s care for millions of families.

During the broadcast, Dr. Pimsler broke down how FDA-approved anti-amyloid therapies—including Leqembi (lecanemab) and Kisunla (donanemab)—can now target and remove amyloid plaques from the brain to help slow cognitive decline in appropriately selected patients with early Alzheimer’s disease, alongside emerging blood-based diagnostics and everyday brain-healthy nutrition.

Segment Highlights

  • Amyloid Plaque Removal: How Leqembi and Kisunla slow cognitive decline in early-stage patients.
  • Earlier Detection: The role of new Alzheimer’s blood tests in identifying pathology sooner.
  • Nutrition & Brain Health: A look at the potential benefits of nutrient-rich foods like beets and okra.

Dr. Mason Blake Pimsler, MD, JD
WABC Global Radio Medical Correspondent
New York Post Contributing Medical Expert